Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of 14-Day Vonoprazan-Based Dual Therapy Versus Quadruple Therapy for Helicobacter Pylori Eradication: A Multicentre, Non-Inferiority Randomized Controlled Trial

NCT07179159 is registered in ClinicalTrials.gov with Yanqing Li as lead sponsor.

NCT NCT07179159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07179159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of 14-Day Vonoprazan-Based Dual Therapy Versus Quadruple Therapy for Helicobacter Pylori Eradication: A Multicentre, Non-Inferiority Randomized Controlled Trial
Lead sponsor
Yanqing Li
Phase
Not applicable
Overall status
Recruiting
Start date
September 9, 2025
Completion date
December 31, 2026
Enrollment
372 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infections